tiprankstipranks
Trending News
More News >
Sanara MedTech (SMTI)
:SMTI
US Market
Advertisement

Sanara MedTech (SMTI) Earnings Dates, Call Summary & Reports

Compare
39 Followers

Earnings Data

Report Date
Apr 01, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.33
Last Year’s EPS
-0.41
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Sanara MedTech demonstrated strong revenue growth and improved profitability, driven by its core surgical business and strategic network expansion. However, the discontinuation of Tissue Health Plus and increased operating expenses pose challenges.
Company Guidance
During the Sanara MedTech third quarter of 2025 earnings call, the company outlined several key metrics and strategic decisions impacting its financial performance and future direction. The company achieved a net revenue of $26.3 million, marking a 22% year-over-year growth, with soft tissue repair product sales increasing by 24% to $23.4 million. Sanara also reported a $1 million improvement in net income from continuing operations and a $2.3 million enhancement in adjusted EBITDA, alongside a 200 basis point increase in gross margin to 93%. Despite these gains, the company announced the cessation of its Tissue Health Plus (THP) operations, a move expected to result in a cash investment between $5.5 million and $6.5 million in the second half of 2025, aligning with previously shared expectations. Looking ahead, Sanara anticipates high single-digit to low-teens revenue growth in the fourth quarter of 2025, excluding a $1.8 million headwind from the previous year's extraordinary demand for BIASURGE. The organization remains focused on driving sustainable growth, optimizing its commercial strategy, and leveraging its strong distributor network and clinical evidence to expand its market presence.
Strong Revenue Growth
Sanara MedTech's surgical team achieved net revenue of $26.3 million in Q3 2025, marking a 22% year-over-year growth, driven by soft tissue repair products.
Improved Profitability
The company reported a $1 million improvement in net income from continuing operations and a $2.3 million increase in adjusted EBITDA on net revenue growth of $4.7 million.
Expansion of Distributor Network
Sanara expanded its network from 300 to over 400 contracted distributors over the last 12 months, enhancing its market reach.
Clinical Evidence and New Product Initiatives
Two studies on CellerateRX were published in peer-reviewed journals, supporting its efficacy in complex surgical procedures. Progress was also made with the OsStic product under the BMI partnership.

Sanara MedTech (SMTI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SMTI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 01, 2026
2025 (Q4)
0.33 / -
-0.41
Nov 12, 2025
2025 (Q3)
-0.21 / -3.40
-0.34-900.00% (-3.06)
Aug 13, 2025
2025 (Q2)
-0.44 / -0.23
-0.4143.90% (+0.18)
May 14, 2025
2025 (Q1)
-0.51 / -0.41
-0.21-95.24% (-0.20)
Mar 25, 2025
2024 (Q4)
-0.12 / -0.18
-0.03-500.00% (-0.15)
Nov 12, 2024
2024 (Q3)
-0.62 / -0.34
-0.13-161.54% (-0.21)
Aug 12, 2024
2024 (Q2)
-0.21 / -0.41
-0.22-86.36% (-0.19)
May 13, 2024
2024 (Q1)
-0.07 / -0.21
-0.14-50.00% (-0.07)
Mar 25, 2024
2023 (Q4)
-0.13 / -0.03
-0.01-200.00% (-0.02)
Nov 13, 2023
2023 (Q3)
0.00 / -0.13
-0.1827.78% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SMTI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$28.04$21.11-24.71%
Aug 13, 2025
$27.47$31.92+16.20%
May 14, 2025
$35.10$31.30-10.83%
Mar 25, 2025
$35.69$31.20-12.58%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sanara MedTech (SMTI) report earnings?
Sanara MedTech (SMTI) is schdueled to report earning on Apr 01, 2026, Before Open (Confirmed).
    What is Sanara MedTech (SMTI) earnings time?
    Sanara MedTech (SMTI) earnings time is at Apr 01, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SMTI EPS forecast?
          SMTI EPS forecast for the fiscal quarter 2025 (Q4) is 0.33.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis